We just received data on a new analyst forecast for $CTAS. Toni Kaplan from Morgan Stanley set a price target of 210.0 for CTAS.
To track analyst ratings and price targets for $CTAS, check out Quiver Quantitative's $CTAS forecast page.
Should you buy $CTAS?
Some analysts are better than others. To view the past performance of Morgan Stanley, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CTAS Price Targets
Multiple analysts have issued price targets for $CTAS recently. We have seen 9 analysts offer price targets for $CTAS in the last 6 months, with a median target of $210.0.
Here are some recent targets:
- Toni Kaplan from Morgan Stanley set a target price of $210.0 on 12/17/2025
- Jason Haas from Wells Fargo set a target price of $185.0 on 11/25/2025
- Connor Cerniglia from Bernstein set a target price of $200.0 on 11/12/2025
- Leo Carrington from Citigroup set a target price of $176.0 on 09/26/2025
- Ashish Sabadra from RBC Capital set a target price of $206.0 on 09/25/2025
- Andrew Steinerman from JP Morgan set a target price of $230.0 on 09/25/2025
- Andrew Wittmann from Baird set a target price of $230.0 on 07/18/2025
$CTAS Insider Trading Activity
$CTAS insiders have traded $CTAS stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CTAS stock by insiders over the last 6 months:
- TODD M. SCHNEIDER (CEO and Director) sold 17,301 shares for an estimated $3,821,790
- RONALD W TYSOE sold 5,084 shares for an estimated $1,136,121
- MARTIN MUCCI purchased 1,200 shares for an estimated $267,060
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CTAS Revenue
$CTAS had revenues of $2.7B in Q1 2026. This is an increase of 8.66% from the same period in the prior year.
You can track CTAS financials on Quiver Quantitative's CTAS stock page.
$CTAS Congressional Stock Trading
Members of Congress have traded $CTAS stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CTAS stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
- REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 09/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CTAS Hedge Fund Activity
We have seen 618 institutional investors add shares of $CTAS stock to their portfolio, and 808 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,568,421 shares (+47.4%) to their portfolio in Q3 2025, for an estimated $321,934,094
- WINSLOW CAPITAL MANAGEMENT, LLC removed 1,403,342 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $288,049,978
- FMR LLC removed 1,002,264 shares (-10.1%) from their portfolio in Q3 2025, for an estimated $205,724,708
- TWO SIGMA INVESTMENTS, LP added 998,963 shares (+5641.3%) to their portfolio in Q3 2025, for an estimated $205,047,145
- QUBE RESEARCH & TECHNOLOGIES LTD added 850,870 shares (+135.8%) to their portfolio in Q3 2025, for an estimated $174,649,576
- VOLORIDGE INVESTMENT MANAGEMENT, LLC added 823,885 shares (+275.2%) to their portfolio in Q3 2025, for an estimated $169,110,635
- FREESTONE GROVE PARTNERS LP added 733,380 shares (+5341.8%) to their portfolio in Q3 2025, for an estimated $150,533,578
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
